XML 41 R47.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Capital Structure (Details) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 28, 2018
Jun. 30, 2016
Jun. 10, 2016
Dec. 31, 2019
Dec. 31, 2018
Jan. 30, 2018
Capital Structure (Textual)              
Preferred stock, par value (in dollars per share)         $ 0.001 $ 0.001  
Preferred stock, shares authorized (in shares)         500,000 500,000  
Common stock, shares authorized (in shares)         40,000,000 40,000,000  
Common stock, par value         $ 0.0001 $ 0.0001  
Warrant exercise price $ 1.25            
Stated value, percentage             5.00%
Issuance of warrants         $ 43,875 $ 1,750  
Common Stock [Member]              
Capital Structure (Textual)              
Common stock, shares authorized (in shares)         40,000,000    
Common stock, par value         $ 0.0001    
Convertible preferred stock, terms of conversion, description         The Company is authorized to issue 40,000,000 shares of $0.0001 par value common stock. Each share of common stock entitles the holder to one vote at all stockholder meetings.    
Preferred Stock [Member]              
Capital Structure (Textual)              
Preferred stock, par value (in dollars per share)         $ 0.001    
Preferred stock, shares authorized (in shares)         500,000    
Series 1 Convertible Preferred Stock [Member]              
Capital Structure (Textual)              
Preferred stock, par value (in dollars per share)         $ 0.001 $ 0.001  
Preferred stock, shares authorized (in shares)         250,000 250,000  
Convertible preferred stock, terms of conversion, description         68,214 shares of Series 1 Convertible Preferred Stock were converted into 86,323 shares of common stock. As of December 31, 2019, there were 171,191 shares of Series 1 Convertible Preferred Stock outstanding, which are convertible at a conversion rate of 1.27404 into 218,104 shares of common stock. The increase in the conversion price from 2018 to 2019 is due to the Series 1 Convertible Preferred Stock anti-dilution adjustment as a result of FPAYW warrants and stock options exercised for common stock.    
Convertible preferred stock, stated value         $ 5 $ 5  
Series 2 Convertible Preferred Stock [Member]              
Capital Structure (Textual)              
Preferred stock, par value (in dollars per share)         $ 0.001    
Preferred stock, shares authorized (in shares)         25,000    
Proceeds from sale of stock       $ 20,000,000      
Convertible preferred stock, shares issued upon conversion         20,000    
Convertible preferred stock, stated value         $ 1,000    
Gross proceeds       $ 1,950,000      
Additional sale of shares       1,952      
Conversion of preferred stock to common stock, shares         257 257  
Cumulative accrued dividends         $ 8,393,084    
Issuance of shares       20,000      
Description of warrants expiration     Initial exercise price of $1,250 per share, which expire seven years after the date of issuance.        
Stated value, percentage         10.00%    
Series 1 Convertible Preferred Stock [Member] | Preferred Stock [Member]              
Capital Structure (Textual)              
Preferred stock, par value (in dollars per share)           $ 1.26547  
Preferred stock, shares authorized (in shares)         250,000 239,405  
Common stock, shares authorized (in shares)         302,960    
Convertible, conversion price per share         $ 1.27404    
Warrant [Member]              
Capital Structure (Textual)              
Exercise price of warrants         $ 0.32    
Common stock warrants outstanding         7,347,388    
Series 2 preferred stock warrants outstanding         439    
Description of common stock offering The Company completed an offering of 10,000,000 units (the "Offering") issued at a price of $1.00 per unit, each unit consisting of one share of the Company's common stock and one-half (1/2) of one warrant, each whole warrant exercisable for one share of common stock at an exercise price $1.25 per warrant. The common stock and warrants included in the units sold in the Offering were immediately separable and issued separately. The Company raised gross proceeds of $10,007,500, less underwriting fees and commissions of 7%, or approximately $0.7 million, and incurred other offering expenses of approximately $0.4 million paid from the proceeds of the offering, resulting in net proceeds of $8.9 million. In connection with the closing of the Offering, the underwriters exercised their over-allotment option to purchase an additional 750,000 warrants for $7,500 with an exercise price of $1.25 per share (see Note 9). Mr. Heiser and NRNS elected to convert 50% of the outstanding principal and accrued interest on their promissory notes into equity interests issued in the Offering (see Note 5). As a result, the Company issued 602,974 shares of common stock and 301,487 warrants to Mr. Heiser and 1,507,395 shares of common stock and 753,697 warrants to NRNS.          
Warrants exercisable for shares of common stock 5,750,000       1,055,184    
Description of warrants expiration The warrants were immediately exercisable and expire five years from the date of issuance.       The warrants are exercisable at $1.25 per share of common stock and expire on September 28, 2023.    
Warrant exercise price $ 1.25       $ 1.25    
Issuance of warrants $ 40,000